Aixtron Se (AIXG) 7.01 $AIXG Aixtron Has Returned 36.9%

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Aixtron Se (AIXG) 7.01 $AIXG

Aixtron Has Returned 36.9% Since SmarTrend Recommendation (AIXG)
Comtex SmarTrend(R) - Mon Apr 20, 11:29AM CDT
SmarTrend identified a Downtrend for Aixtron (NASDAQ:AIXG) on October 30th, 2014 at $11.76. In approximately 6 months, Aixtron has returned 36.88% as of today's recent price of $7.42.
AIXG: 7.01 (-0.26)

Aixtron drops on Berenberg downgrade; Veeco also off
Seeking Alpha - at Seeking Alpha - Wed Apr 08, 11:43AM CDT

AIXG: 7.01 (-0.26), VECO: 31.24 (+0.10)

Aixtron Down 34.0% Since SmarTrend Downtrend Call (AIXG)
Comtex SmarTrend(R) - Mon Apr 06, 10:02AM CDT
SmarTrend identified a Downtrend for Aixtron (NASDAQ:AIXG) on October 30th, 2014 at $11.76. In approximately 5 months, Aixtron has returned 33.99% as of today's recent price of $7.76.
AIXG: 7.01 (-0.26)

Notable tech gainers: YOKU, VHC, CALL, COUP, NSR, VECO, AIXG
Seeking Alpha - at Seeking Alpha - Thu Apr 02, 2:20PM CDT

COUP: 13.11 (+0.33), NSR: 28.00 (+0.64), JOBS: 35.82 (-0.01), AIXG: 7.01 (-0.26), VECO: 31.24 (+0.10), CALL: 6.78 (-0.15), YOKU: 16.42 (-0.21), USAT: 2.80 (+0.03), VHC: 6.85 (+0.22)

Chip stocks slump again after SanDisk warns; TSMC remarks in focus
Seeking Alpha - at Seeking Alpha - Thu Mar 26, 9:50AM CDT

SOXS: 10.74 (-0.45), AMBA: 74.57 (+0.18), CAVM: 73.16 (+0.39), AIXG: 7.01 (-0.26), SWKS: 96.83 (+1.41), VECO: 31.24 (+0.10), SOXL: 148.06 (+5.89), TSM: 23.84 (+0.51), SMH: 57.23 (+1.02), SOXX: 96.88 (+1.35), NXPI: 102.69 (+1.45), ACLS: 2.64 (unch), SSG: 44.90 (-1.38), KLIC: 15.66 (+0.01), PSI: 27.65 (+0.19), QRVO: 74.48 (+0.41), USD: 94.68 (+1.94), FSL: 41.53 (+0.49), STM: 9.94 (+0.29), XSD: 89.10 (+0.13)

35.9% Return Seen to Date on SmarTrend Aixtron Call (AIXG)
Comtex SmarTrend(R) - Thu Mar 19, 11:22AM CDT
SmarTrend identified a Downtrend for Aixtron (NASDAQ:AIXG) on October 30th, 2014 at $11.76. In approximately 5 months, Aixtron has returned 35.86% as of today's recent price of $7.54.
AIXG: 7.01 (-0.26)

Micron ticks higher, chip equipment firms slump on Samsung DRAM report
Seeking Alpha - at Seeking Alpha - Wed Mar 18, 10:16AM CDT

MU: 29.50 (+0.95), AIXG: 7.01 (-0.26), LRCX: 78.36 (+0.52), ACLS: 2.64 (unch), MTSN: 3.73 (+0.07)

Shares of AIXG Down 35.2% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Thu Mar 12, 10:14AM CDT
SmarTrend identified a Downtrend for Aixtron (NASDAQ:AIXG) on October 30th, 2014 at $11.76. In approximately 4 months, Aixtron has returned 35.18% as of today's recent price of $7.62.
AIXG: 7.01 (-0.26)

Aixtron Aktiengesellschaft's (AIXG) CEO Martin Goetzeler on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Tue Feb 24, 3:34PM CST

AIXG: 7.01 (-0.26)

Aixtron Aktiengesellschaft misses by €0.09, beats on revenue
Seeking Alpha - at Seeking Alpha - Tue Feb 24, 5:46AM CST

AIXG: 7.01 (-0.26)

Notable earnings before Tuesday’s open
Seeking Alpha - at Seeking Alpha - Mon Feb 23, 4:30PM CST

AMT: 95.92 (+0.94), UTHR: 187.98 (+0.12), TREX: 51.48 (-0.49), GLDD: 5.81 (-0.04), THRM: 52.18 (+0.02), SUI: 64.54 (+0.43), CYRN: 3.31 (+0.01), EXLS: 33.14 (-0.11), AIXG: 7.01 (-0.26), WLK: 75.87 (+0.16), COT: 9.11 (-0.03), SPAR: 5.02 (+0.02), SAH: 24.44 (+0.22), DYAX: 28.12 (+0.15), GTLS: 40.68 (+0.51), VAL: 83.95 (-0.05), SHOO: 37.67 (+0.40), CBRL: 137.40 (-1.10), WPC: 65.58 (+0.20), EXPD: 46.62 (-0.30), TRXC: 3.47 (-0.05), WEN: 10.44 (unch), CEQP: 6.73 (+0.09), CMLP: 15.62 (-0.16), CLDT: 29.07 (-0.11), CLDX: 28.95 (+1.08), SAFM: 78.03 (-0.62), M: 67.00 (-0.03), SPWR: 34.74 (+0.28), WIN: 8.41 (+0.06), DCI: 37.47 (+0.09), CRNT: 1.39 (+0.15), IART: 59.75 (-0.26), DPZ: 99.80 (+0.40), CRZO: 52.72 (+0.32), ECL: 116.05 (+0.17), BMO: 65.11 (+0.05), DAKT: 11.26 (+0.23), HD: 112.99 (-0.18), SHLX: 38.86 (-0.05), NEO: 4.83 (-0.04), EXAS: 22.28 (+0.24), ALKS: 62.60 (-0.24), MNKD: 4.90 (-0.09), FDML: 13.10 (-0.17), DRH: 13.90 (+0.03), IPXL: 49.58 (-0.40), ZINC: 13.72 (-0.12), VSI: 44.50 (+5.54), PLL: 97.75 (-0.81), RLGY: 46.91 (+0.71), ODP: 9.25 (-0.09), PF: 41.01 (-0.40), CMCSA: 58.76 (-0.08), PCRX: 83.61 (-0.41), TOL: 37.62 (-1.16)

Aixtron Shares Down 30.7% Since SmarTrend's Sell Call (AIXG)
Comtex SmarTrend(R) - Wed Feb 18, 11:05AM CST
SmarTrend identified a Downtrend for Aixtron (NASDAQ:AIXG) on October 30th, 2014 at $11.76. In approximately 4 months, Aixtron has returned 30.67% as of today's recent price of $8.15.
AIXG: 7.01 (-0.26)

Downtrend Call Working As Aixtron Stock Falls 29.2% (AIXG)
Comtex SmarTrend(R) - Wed Feb 11, 9:46AM CST
SmarTrend identified a Downtrend for Aixtron (NASDAQ:AIXG) on October 30th, 2014 at $11.76. In approximately 3 months, Aixtron has returned 29.22% as of today's recent price of $8.32.
AIXG: 7.01 (-0.26)

29.0% Return Seen to Date on SmarTrend Aixtron Call (AIXG)
Comtex SmarTrend(R) - Tue Jan 27, 5:02PM CST
SmarTrend identified a Downtrend for Aixtron (NASDAQ:AIXG) on October 30th, 2014 at $11.76. In approximately 3 months, Aixtron has returned 28.97% as of today's recent price of $8.35.
AIXG: 7.01 (-0.26)

Shares of AIXG Down 17.0% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Tue Jan 13, 1:12AM CST
SmarTrend identified a Downtrend for Aixtron (NASDAQ:AIXG) on October 30th, 2014 at $11.76. In approximately 2 months, Aixtron has returned 16.97% as of today's recent price of $9.76.
AIXG: 7.01 (-0.26)

China reportedly ending LED subsidies
Seeking Alpha - at Seeking Alpha - Mon Dec 22, 2:51PM CST

AIXG: 7.01 (-0.26), VECO: 31.24 (+0.10), LEDS: 0.88 (unch), RBCN: 3.85 (+0.06), CREE: 32.36 (-3.04)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 6

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 7

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 6

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 7

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 3

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 7

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 6

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 6

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 15

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading

Top 5 Most Recently Viewed Articles

ANI Pharmaceuticals Plans to Shine at Biotech Conference

Updated Category News Views 257

ANI Pharmaceuticals Set for Key Presentation at Biotech Conference ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) is gearing up to showcase its advancements at the Guggenheim Biotech Conference. On an exciting date, Nikhil Lalwani, the Company’s President and CEO, along with Stephen Carey, the CFO, will host a fireside chat to discuss the latest developments and future plans...

Continue Reading
New Shuttle Drives Economic Recovery on O'ahu

Updated Category News Views 26

Reviving the North Shore Economy, One Shuttle Ride at a Time Not every day do you see a $5 investment with such community punch. On June 29, a new bus service launches, whisking folks from Waik?k? and Ko Olina to O?ahu’s North Shore. But this ain't just another tourist bus ride—it's a lifeline for local businesses hit hard by March's kona low storms. Connecting...

Continue Reading
Virginia Cancer Specialists Expands Services with New Center

Updated Category News Views 21

Virginia Cancer Specialists Expands its Reach with a New Center Virginia Cancer Specialists, a leading private cancer practice in the region, has announced the opening of their newly expanded cancer center. This important development aims to enhance patient care and provide access to the latest cancer treatments. The expansion not only signifies growth but also a...

Continue Reading
Key Financial Dates for TCM Group A/S's Upcoming Year

Updated Category News Views 167

Important Financial Calendar for TCM Group A/S TCM Group A/S is a significant player in the kitchen and furniture manufacturing industry. As the year approaches its end, the company has established key dates for reporting and annual meetings, signaling to shareholders and stakeholders the importance of staying informed. Scheduled Report Releases and Meetings The Board of...

Continue Reading
Unexpected Chicago PMI Falls Raises Concerns for Manufacturing

Updated Category News Views 323

Understanding the Recent Chicago PMI Decline Recently, the Chicago Purchasing Managers' Index (PMI) reported a surprising score of 36.9, highlighting ongoing challenges in the manufacturing sector within the region. This score is a clear indication that the manufacturing landscape in Chicago is experiencing significant contraction, a worrisome sign for the local and...

Continue Reading